Saturday 17 October 2026 Export AKBA’s income statement to Excel — free account

Akebia Therapeutics, Inc.

AKBA Healthcare Drug Manufacturers Specialty & Generic

Akebia Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $236.2 million, up 47.5% from fiscal 2024. In the quarter to June 2026, revenue fell 21.4%, EPS fell 3,433.3%, free cash flow fell 89.0% and total debt rose 5.31%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.67 0.03 −4.29%

Follow AKBA

Alert me

Market cap: $192.7M
P/E: 0.0×
Fwd P/E: −6.3×
Dividend yield: —
F-score: 7/9
Altman Z: −4.42
Beneish M: −3.16
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		3.21	1.75	1.60	1.40
P/FCF ratio Full definition →		22.35	6.10	6.18	7.63
P/Operating CF Full definition →		25.72	13.30	(17.50)	87.19
P/B ratio Full definition →		17.38	12.70	13.56	12.29
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		2.76	1.25	1.11	0.92
EV/EBITDA Full definition →		22.17	11.91	39.17	0.00
EV/Operating CF Full definition →		19.19	4.34	4.26	4.85
EV/FCF Full definition →		19.22	4.35	4.29	5.00
Quick Ratio Full definition →		1.74	1.42	1.30	1.30
Current Ratio Full definition →		1.94	1.55	1.40	1.43
Net Debt/EBITDA Full definition →		(24.92)	16.59	26.04	18.46
Debt/Assets Full definition →		13.08%	12.81%	13.49%	14.17%
Debt/Equity Full definition →		1.15	1.48	1.79	1.98
Asset Turnover Full definition →		0.79	0.79	0.69	0.63
Operating CF/Net income Full definition →		52.05	(2.54)	2.34	(0.40)
Capex/Depreciation Full definition →		(0.24)	(0.22)	(0.19)	(1.84)
Interest Coverage Full definition →		0.94	(1.77)	(1.00)	(2.06)
Research and Development Expense of Revenue Full definition →		25.43%	46.25%	27.65%	28.62%
Selling, General and Administrative Expense of Revenue Full definition →		49.51%	45.28%	56.84%	57.34%
Intangible Assets out of Total Assets Full definition →		0.16	0.16	0.16	0.17
Share Based Compensation of Revenue Full definition →		5.48%	5.55%	6.85%	6.57%
Graham Net Nets Full definition →		(0.09)	(0.22)	(0.25)	(0.31)
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(2.46%)	(1.06%)	(5.55%)	(9.47%)
Free Cash Flow Yield Full definition →		4.47%	16.39%	16.17%	13.10%
Revenue per Share Full definition →		0.22	0.22	0.20	0.18
Operating CF per Share Full definition →		0.11	0.12	(0.08)	0.01
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.11	0.12	(0.08)	0.01
Cash per Share Full definition →		0.63	0.72	0.61	0.58
Shareholders Equity per Share Full definition →		0.16	0.13	0.10	0.09
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		0.16	0.13	0.10	0.09
Free Cash Flow Full definition →		28.03	31.06	(21.27)	2.45
Working Capital Full definition →		124.96	90.02	69.60	68.69
Capital Expenditures Full definition →		(0.08)	(0.07)	(0.06)	(1.08)
Net Current Asset Value Full definition →		(64.22)	(91.00)	(91.66)	(95.09)
EV/EBIT Full definition →		35.03	12.55	48.67	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.02
Price to Operating Income Full definition →		40.73	17.62	70.18	0.00
Other line items
Average Receivables Full definition →		49.20	40.70	62.04	63.16
Average Payables Full definition →		11.79	18.18	10.52	10.49
Average Inventory Full definition →		19.57	15.93	16.36	14.86
Average Assets Full definition →		285.65	298.62	336.35	347.63
Average Common Equity Full definition →		(4.41)	(8.29)	25.98	27.12

Show all line items

Columns are period end dates

Stockrow Weekly